These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7327618)
21. Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Med J Aust; 1979 Oct; 2(8):432. PubMed ID: 45557 [No Abstract] [Full Text] [Related]
22. Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Carson CC Tech Urol; 1997; 3(3):135-9. PubMed ID: 9422444 [TBL] [Abstract][Full Text] [Related]
24. Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. Nachtsheim DA; Rearden A J Urol; 1996 Oct; 156(4):1330-4. PubMed ID: 8808864 [TBL] [Abstract][Full Text] [Related]
25. Surgical treatment of Peyronie's disease. Carson CC Can J Urol; 2006 Feb; 13 Suppl 1():28-33. PubMed ID: 16526978 [TBL] [Abstract][Full Text] [Related]
26. Prospective analysis of 16S rDNA as a highly sensitive marker for bacterial presence in Peyronie's disease plaques. Hauck EW; Domann E; Hauptmann A; Weidner W; Chakraborty T; Hossain HM J Urol; 2003 Nov; 170(5):2053-6. PubMed ID: 14532852 [TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of Peyronie's disease based on penile length and degree of curvature. Bokarica P; Parazajder J; Mazuran B; Gilja I Int J Impot Res; 2005; 17(2):170-4. PubMed ID: 15215882 [TBL] [Abstract][Full Text] [Related]
33. Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease. Haag SM; Hauck EW; Szardening-Kirchner C; Diemer T; Cha ES; Weidner W; Eickelberg O Eur Urol; 2007 Jan; 51(1):255-61. PubMed ID: 16782264 [TBL] [Abstract][Full Text] [Related]
34. Plaque incision and grafting as a salvage after a failed Nesbit procedure for Peyronie's disease. Muneer A; Kalsi J; Christopher N; Minhas S; Ralph DJ BJU Int; 2004 Oct; 94(6):878-80. PubMed ID: 15476526 [TBL] [Abstract][Full Text] [Related]
35. Peyronie's disease associated with methotrexate therapy. May CM; Burden D; Palmer MA; Leman JA Clin Exp Dermatol; 2009 Oct; 34(7):e467-8. PubMed ID: 19747316 [No Abstract] [Full Text] [Related]
36. Penile dermal flap for defect reconstruction in Peyronie's disease: operative technique and four years' experience in 17 patients. Krishnamurti S Int J Impot Res; 1995 Dec; 7(4):195-208. PubMed ID: 8770663 [TBL] [Abstract][Full Text] [Related]
37. Peyronie's disease with erectile dysfunction: penile modeling over inflatable penile prostheses. Chaudhary M; Sheikh N; Asterling S; Ahmad I; Greene D Urology; 2005 Apr; 65(4):760-4. PubMed ID: 15833523 [TBL] [Abstract][Full Text] [Related]
38. Peyronie's disease in systemic sclerosis. Report of two cases. Gualdieri L; Valentini G; Lupoli S; Giordano M J Rheumatol; 1988 Feb; 15(2):380-1. PubMed ID: 3361551 [No Abstract] [Full Text] [Related]
39. FastSize Medical Extender for the treatment of Peyronie's disease. Levine LA; Newell MM Expert Rev Med Devices; 2008 May; 5(3):305-10. PubMed ID: 18452379 [TBL] [Abstract][Full Text] [Related]
40. Iontophoresis for treatment of Peyronie's disease. Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]